Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E.

MLA

Robert, Jerome, et al. “Cerebrovascular Amyloid Angiopathy in Bioengineered Vessels Is Reduced by High-Density Lipoprotein Particles Enriched in Apolipoprotein E.” Molecular Neurodegeneration, vol. 15, no. 1, Mar. 2020, pp. 1–21. EBSCOhost, https://doi.org/10.1186/s13024-020-00366-8.

APA

Robert, J., Button, E. B., Martin, E. M., McAlary, L., Gidden, Z., Gilmour, M., Boyce, G., Caffrey, T. M., Agbay, A., Clark, A., Silverman, J. M., Cashman, N. R., & Wellington, C. L. (2020). Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E. Molecular Neurodegeneration, 15(1), 1–21. https://doi.org/10.1186/s13024-020-00366-8

Chicago

Robert, Jerome, Emily B. Button, Emma M. Martin, Luke McAlary, Zoe Gidden, Megan Gilmour, Guilaine Boyce, et al. 2020. “Cerebrovascular Amyloid Angiopathy in Bioengineered Vessels Is Reduced by High-Density Lipoprotein Particles Enriched in Apolipoprotein E.” Molecular Neurodegeneration 15 (1): 1–21. doi:10.1186/s13024-020-00366-8.